The American drug maker will pay $830 million to investors who bought Merck securities between 1999 and 2004.
The lawsuit stemmed from statements Merck made about the cardiovascular safety of Vioxx.
Vioxx was withdrawn from the market in 2004 after evidence showed it doubled the risk of heart attack and stroke.
In 2011, Merck pleaded guilty to federal charges of violating marketing laws related to its sale of Vioxx.
Federal officials accused Merck of making false statements and illegally marketing Vioxx as a treatment for rheumatoid arthritis to increase sales.
The company said this latest settlement with investors did not constitute an admission of guilt by the drug maker.
Merck still faced a number of individual lawsuits related to Vioxx.
President Joe Biden has urged pro-Palestinian protesters on university campuses to uphold the rule of…
Blue Ivy Carter has joined the voice cast of The Lion King prequel Mufasa: The…
At least five people, including a four-month-old baby, have been killed after dozens of tornadoes…
Harvey Weinstein has been hospitalized just days after his 2020 rape conviction in New York…
Hamas has published a video showing the first proof of life of US and Israeli…
Prosecutors and Donald Trump’s attorneys delivered opening statements and the first witness was called on…